Sichuan Maker Biotechnology, an in-vitro diagnostic reagents producer, plans to acquire 24.2% stake in Jiashan JASDAQ Medical Device Co Ltd for CNY15m ($2.27m). The acquisition will increase Sichuan’s share in the company to 57.2%.

Breast cancer prognostic company, Sividon Diagnostics GmbH has been acquired by Myriad Genetics, a molecular diagnostic company based in the US.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Myriad Genetics has agreed to pay up to €50m ($55.61m), of which €35m ($38.93m) will be paid as an upfront payment and the remaining will be paid at performance-based milestones.

"Myriad Genetics has agreed to pay up to €50m ($55.61m), of which €35m ($38.93m) will be paid as an upfront payment and the remaining will be paid at performance-based milestones."

The transaction, which was closed on 31 May 2016, allows Myriad Genetics to add Sividon Diagnostics’ EndoPredict test, a popular breast cancer prognostic test, to its global oncology distribution thus enabling it to strengthen its oncology portfolio of high-value, personalised medicine products.

Yestar International Holdings Company plans to acquire a China-based medical device company from an independent third party

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact